Parkinson's disease nurse specialists have minimal effect on patients' clinical condition

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.362, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?

Current Medicinal Chemistry, Vol. 25, Iss. 31, 2018-09 ,pp. : 3682-3702

Bentham Science Publishers

Access to resources Recommend Favorite

Fetal Tissue Transplantation for Patients with Parkinson's Disease: A Database of Published Clinical Results

By Clarkson E.D.

Drugs & Aging, Vol. 18, Iss. 10, 2001-10 ,pp. : 773-785

Adis International

Access to resources Recommend Favorite

Catechol- O -Methyl Transferase (COMT) Inhibitors in Patients with Parkinson's Disease: Is COMT Genotype a Useful Indicator of Clinical Efficacy?

By Rinne J.O.

American Journal of PharmacoGenomics, Vol. 3, Iss. 1, 2003-01 ,pp. : 11-15

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology of Dopamine Agonists in Parkinson's Disease

By Lange K.W.

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 381-389

Adis International

Access to resources Recommend Favorite

Implementing NICE clinical guidelines on Parkinson’s disease

By Ryton Beverly A Liddle B Jane

Clinical Medicine, Vol. 9, Iss. 5, 2009-10 ,pp. : 436-440

Royal College Of Physicians

Access to resources Recommend Favorite